Natural killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)

Clinical and Experimental Immunology

Volumn 103, Issue 3, 1996, Pages 408-413

  Jawahar, S ^a   Moody, C ^a   Chan, M ^b   Finberg, R ^b   Geha, R ^a   Chatila, T ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

CD16; Fc receptors; Herpes; Immunodeficiency; Natural killer cells; Viruses

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; FC RECEPTOR;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOPENIA; DISEASE PREDISPOSITION; DNA SEQUENCE; HERPES VIRUS INFECTION; HUMAN; IMMUNE DEFICIENCY; MUTANT; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0029892132     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1996.tb08295.x     Document Type: Article

References (31)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47:187-37.
2. Lopez C, Kirkpatrick D, Fitzgerald P. The role of NK (HSV-1) effector cells in the resistance to herpes virus infections in man, in NK cells and other effector cells. In: Herberman RB, ed. New York: Academic Press, 1982.
3. Quinnan GVJ, Kirmani N, Rook AH, Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 1982; 307:7-13.
4. Bukowsky JF, Woda BA, Habu S, Okumura K, Welch RM. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983; 131:1531-8.
5. Habu S, Akamatsu K, Tamaoki N, Okumura. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J Immunol 1984; 133:2743-7.
6. Bukowski JF, Warner JF, Dennert G, Welsh RM. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med 1985; 161:40-52.
7. Garcia-Penarrubia P, Koster FT, Kelly RO, McDowell TD, Bankhurst AD. Antibacterial activity of human natural killer cells. J Exp Med 1989; 169:99-113.
8. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989; 320:1731-5.
9. + subset. J Allergy Clin Immunol 1990; 85:453-9.
10. Lanier LL, Testi R, Bindl J, Philips JH. Identity of Leu19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule (N-CAM). J Exp Med 1989; 169:2233-8.
11. Lanier LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Philips JH. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/ CD56). J Immunol 1991; 146:4421-6.
12. Ravetch JV, Kinet J-P. Fc receptors. Annu Rev Immunol 1991; 9:457-92.
13. Ravetch JV, Perussia B. Alternative membrane forms of FcγRIII (CD16) on human NK cells and neutrophils: cell-type specific expression of 2 genes which differ in single nucleotide substitutions. J Exp Med 1989; 170:481-97.
14. Selvaraj P, Rosse WF, Silber R, Springer TA. The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal hemoglobinuria. Nature 1988; 333:565-7.
15. Simmons D, Seed B. The FcγR of natural killer cells is a phospholipid-linked membrane protein. Nature 1988; 333:568-70.
16. Huizinga TWJ, Van der School CE, Jost C et al. The PI-linked receptor FcγRIII is released on stimulation of neutrophils. Nature 1988; 333:667-9.
17. Selvaraj P, Carpen O, Hibbs ML, Springer TA. Natural killer cell and granulocyte FcγRIII (CD16) differ in membrane anchor and signal transduction. J Immunol 1989; 143:3283.
18. Finberg RW, Newburger JW, Mikati MA, Heller AH, Burns JC. Effects of high doses of intravenously adminstered immune globulin on natural killer cell activity in peripheral blood. J Peds 1992; 120:376-80.
19. Anderson CL, Looney RJ, Clup DJ et al. Human alveolar and peritoneal macrophages bear three distinct classes of Fc receptors for IgG. J Immunol 1990; 145:196.
20. Perussia B, Trinchieri G, Jackson A et al. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol 1984; 133:180-9.
21. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 1981; 68:932-41.
22. Caligiuri MA, Zmuidzians A, Manely TJ, Levine H, Smith KA, Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med 1990; 171:1509-26.
23. Nagler A, Lanier LL, Philips JH. Constitutive expression of high affinity interleukin 2 receptors on human CD16 natural killer cells in vivo. J Exp Med 1990; 171:1527-33.
24. Hibbs ML, Tolvanen M, Carpen O. Membrane-proximal Ig-like domain of FcγRIII (CD16) contains residues critical for ligand binding. J Immunol 1994; 152:4466-74.
25. Scallon BJ, Scigliano E, Freedman VH, Miedel MC, Pan Y-CE, Unkless JC, Kochan JP. A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositolglycan-anchored forms. Proc Natl Acad Sci USA 1989; 86:5079-83.
26. Lanier LL, Cwirla S, Yu G, Testi R, Philips JH. Membrane anchoring of a human IgG Fc receptor (CD16) determined by a single amino acid. Science 1989; 246:1611-3.
27. Trounstine ML, Peltz GA, Yssel H, Huizinga TWJ. von dem Borne AEK, Spits H, Moore K. Reactivity of cloned, expressed human FcγRIII isoforms with monoclonal antibodies which distinguish cell-type specific and allelic form of FcγRIII. Int Immunol 1990; 2:303-10.
28. Peltz GA, Grundy HO, Lebo RV, Yessel H, Brash GS, Moore KW. Human Fc gamma RIII: cloning, expression and identification of an Fc-gamma receptor chromosomal locus. Proc Natl Acad Sci USA 1989; 86:1013-7.
29. Hibbs ML. Selvaraj P, Capen O, Springer OA, Kuster H, Jouvin M, Kinet J-P. Mechanisms for regulating expression of membrane isoforms of FcγRIIIA (CD16). Science 1989; 246:1608-11.
30. de Vries E, Van Tol MJD, Koene HR, De Haas M, von dem Borne AEGK, Gratama JW, Vossen JM. A patient with recurrent infections associated with an aberrant Fc receptor (CD16) molecule on natural killer cells. In: Proc. of the 9th International Congress of Immunology, 1995, San Francisco, CA. (Abstr. 2267.)
31. Leibson PJ. MHC-recognizing receptors: they're not just for T cells any more. Immunity 1995; 3:5-8.